Literature DB >> 10760352

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.

J E Lindeboom1, J H Kingma, H J Crijns, P H Dunselman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10760352     DOI： 10.1016/s0002-9149(99)00927-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

Review 1.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Authors:  Omar F Hassan; Jassim Al Suwaidi; Amar M Salam
Journal:  J Atr Fibrillation       Date:  2013-06-30

3.  Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.

Authors:  G Nichol; F McAlister; B Pham; A Laupacis; B Shea; M Green; A Tang; G Wells
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 4.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Advances in the acute pharmacologic management of cardiac arrhythmias.

Authors:  Andrea Sarkozy; Paul Dorian
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

6.  Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.

Authors:  Helena Carstensen; Line Kjær; Maria Mathilde Haugaard; Mette Flethøj; Eva Zander Hesselkilde; Jørgen K Kanters; Steen Pehrson; Rikke Buhl; Thomas Jespersen
Journal:  J Cardiovasc Pharmacol       Date:  2018-01       Impact factor: 3.105

7.  Inhibition of KCa2 and Kv11.1 Channels in Pigs With Left Ventricular Dysfunction.

Authors:  Carlotta Citerni; Jeppe Kirchhoff; Lisbeth Høier Olsen; Stefan Michael Sattler; Morten Grunnet; Nils Edvardsson; Bo Hjorth Bentzen; Jonas Goldin Diness
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.